当前位置: 首页 > 期刊 > 《齐齐哈尔医学院学报》 > 2006年第1期
编号:10980457
萘普生治疗活动性肺结核低热及并发症的临床研究
http://www.100md.com 《齐齐哈尔医学院学报》 2006年第1期
痛风,吡嗪酰胺,,萘普生,低热,肺结核,痛风,吡嗪酰胺,1资料与方法,2结果,3讨论,参考文献
     【摘要】 目的 探讨萘普生对活动性肺结核患者发热及并发症的疗效评价。方法 采用双盲随机方法选出80例符合活动性肺结核标准的病例分治疗组与对照组,分别用萘普生为治疗组药物、VitB1为对照组药物给予治疗,疗程为30日。每日测试体温,密切观察服用抗结核药物(PZA)后出现的并发症进行治疗前后比较。结果 服用萘普生组30日内为100%,而对照组30日内为87.5%,两组对比有非常显著性差异(P<0.01);痛风症状的出现情况,治疗组为零。对照组出现4例为10%两组对比P<0.05,有显著性差异。结论 萘普生作为一种活动性肺结核发热及服用PZA药物引起的痛风症状有明显的治疗、预防作用。在活动性肺结核患有发热症状及应用抗结核药PZA出现的痛风之并发症时,应用萘普生对症治疗是安全有效的方法之一。

    【关键词】 萘普生 低热/肺结核 痛风/吡嗪酰胺

    The Clinical Study of Nqpxen Tablet to Cure the Movable Tuberculosis Low Hot and Its Complications

    Yan Taiyi, et al.

    (Linyi Pectoral Hospital, Linyi, Shandong 276002 China)

    【Abstract】 Objective To inquire the effects of Naproxen Tablets to the movable tuberculosis and the sufferer having fever with complications.Methods To adopt double blind method and choose 80 patients who matched the standard case in tuberculosis. They were divided into curable group and comparable group. Naproxen Tablets respectively was given to curing VitB1 as the matched control medicine give treatment, treatment process was 30 days. Daily measure of the body temperature, close observation of taking the complications that anti- tubercle medicine(PZA) appeared behind the treatment to compare the date before and after.Results Taking the Naproxen Tablets Tablets was 100% in 30 days, but was 87.5% in the comparable group, the difference was obvious(P<0.01)The emergence circumstance of the gout symptom in the treatment set was zero. The matched control group appeared that 4 examples were 10% (P<0.05), having the obvious difference.Conclusions The Naproxen Tablets Tablets can be used for treating tuberculosis with fever and the medicine of PZA, and it is one of the safe and valid methods to cure the complicated symptom. ......

您现在查看是摘要页,全文长 7402 字符